The development of diagnostic techniques to assess anaemia in aquaculture reared Atlantic Salmon (Salmo Salar).

Lead Research Organisation: University of the West of Scotland
Department Name: School of Computing, Eng & Physical Sci

Abstract

Over the last 12 months anaemia has emerged as a significant threat to fish health in salmon aquaculture in Scotland. Anaemia occurs when there is a lack of red blood cells, reducing the oxygen carrying capacity of the blood and negatively impacting on fish health and production. Through recent SAIC project meetings with the aquaculture partners it was highlighted that the industry has limited practical methods to define the type of anaemia occurring, identify its source and subsequently develop a preventative strategy against it. The Scottish aquaculture industry is looking to establish a haematology monitoring programme, to characterise and quantify the impact of anaemia, but does not currently have access to automated technologies for fish haematology and is reliant on slow, labour intensive and subjective manual techniques. This lack of technological advancement has also resulted in a lack of reference data for the establishment of appropriate 'normal' background levels.

The overall aim of this project is the development and validation of efficient methods to assess anaemia in Atlantic salmon in aquaculture that can be adopted by the industry and included into their regular fish health management programmes. This is being undertaken by the validation of existing veterinary and medical haematology devices for assessment of fish blood, which is considerably more difficult owing to fish blood cells being nucleated. However once the relevant techniques are established and validated they shall be used to investigate anaemia in fish and to put those results into the wider context of fish health measured using high throughput, automated medical technologies to assess clinical chemistry and immunology endpoints validated for use with fish in a separate (SAIC funded) project involving the same collaborative partners.

The main benefit and impact of this research shall be improvements in fish health management, increasing fish welfare and growth, subsequently benefiting the industry by a reduction in costs, increased yield and improved product quality.

The development of an appropriate diagnostic system to assess anaemia in salmon aquaculture requires; a) the development and validation of rapid, automated haematological methods for salmon blood, and b) the integration of this haematology data with relevant endpoints on fish health and disease. A holistic diagnostic approach is taken, placing the haematology findings in the context of fish health investigated by the high throughput assessment of biochemistry and immunology endpoints and histological analysis. This innovative approach provides information on the cause of anaemia, thereby allowing identification of solutions. Innovation is needed in the area of blood sample preparation and storage, data interpretation and particularly with the integration of physiological impacts associated with anaemia. There is a current lack of reference values in fish haematology and this work shall contribute towards the establishment of reference data of benefit to the salmon aquaculture industry in Scotland.

In the final stage of the project anaemia in Atlantic salmon from various sites around Scotland shall be identified, defined, quantified and its impact measured using haematological, clinical chemistry and immunology high-throughput analysers integrated into a pro-active mechanised technologically advanced method to assess fish heath.

These techniques are relevant to the salmon aquaculture industry in the UK and internationally and user friendly practical guides and protocols shall be developed along with an engagement workshop to offer hands on training and practice to encourage the inclusion of these techniques throughout the industry, greatly increasing the impact of this research.

Technical Summary

The overall project aim is the creation and integration into fish health management of an efficient diagnostic system to assess anaemia in salmon aquaculture that will ultimately lead to a better understanding of disease, rapid diagnosis and increased fish welfare. The specific objectives of the project are:

1) To work with the veterinary and human medical companies to re-purpose and validate laboratory and point of care instruments for haematological analysis of salmon blood in aquaculture: Training in manual haematological methods and morphological haematology shall be undertaken and used for the validation of the novel automated techniques. Detailed non-specialist protocols shall be developed for automated haematology measurements and data interpretation.

2) To use these techniques for the characterisation of anaemia in salmon: Anaemia is a complex condition induced by numerous endogenous and exogenous factors and can involve mechanisms of impaired erythropoiesis, accelerated haemolysis or haemorrhaging. Novel automated techniques will be used to characterise anaemia.

3) To investigate the relationship between anaemia and other stressors in salmon aquaculture and their impact on fish health and immunology: Haematology data needs to be placed in the context of fish health and integrated with relevant endpoints on fish health and disease. Various clinical chemistry and immunology endpoints are investigated using the high-throughput, automated Randox Daytona clinical chemistry analyser, validated for use on fish in a SAIC funded project.

4) To develop a haematology monitoring programme integrated into the work streams of our aquaculture partners: we are focusing on relatively simple, high throughput, rapid, inexpensive technologies to provide the industry with the practical tools needed to integrate widespread analysis of anaemia into their fish health monitoring programmes.

Planned Impact

The impact of the project shall be measured on several levels:

Societal: through improved fish health and welfare following the integration of haematology providing rapid identification of the early onset of anaemia, allowing faster implementation of mitigation measures and reduced medical intervention.
Economic: by the reduction of anaemia related costs including mortality, food wastage and health management costs and an increase in productivity increasing company profitability. Automation in fish health diagnostics will help health managers to better streamline their activities, increasing productivity.
Scientific: investigation and knowledge creation into the relationship between anaemia and fish health and the development of automated analysers will facilitate analysis of larger sample numbers and the establishment of meaningful reference intervals. Scientific outputs by way of academic publications.
Environmental: from reduced food waste and use of medication. Environmental benefits shall be seen in the decrease in feed wastage by reducing both the amount of feed needed and the potential level of nutrient enrichment around the cages. Healthier fish shall potentially require less medical intervention, again quantifiable before and after the project.
Knowledge exchange: access of this technology through the publication of research findings in peer reviewed scientific journals, the creation of industry-focused technical booklets and a workshop to demonstrate the application of these techniques creating a wider impact throughout the industry.

The results generated by the project shall be disseminated through both academic and industry publications to ensure the widest possible exposure and shall be covered under an IP agreement acceptable to all partners.

The main benefit from this research shall be seen by the industry partners and by the wider Scottish aquaculture industry as they shall be provided with practical tools for the haematological analysis of fish blood using rapid, automated technique enabling the quick assessment of anaemia in fish. When used in conjunction with the clinical chemistry analyser for biochemical and immunological endpoints this offers a potent tool for a holistic assessment of anaemia and fish health in general.

The proposed development of an in-house rapid, high throughput, cost efficient method to analyse anaemia and its impact on fish health based on haematology and the expression of various clinical chemistry endpoints will provide information on fish health in general and on specific organs in particular, acting as an early warning signal, evident before the physiological or pathological symptoms become apparent and allowing the early deployment of mitigation or treatment measures; preventing spread of disease, loss of condition and death.

Publications

10 25 50
publication icon
Currie AR (2022) Anemia in salmon aquaculture: Scotland as a case study. in Aquaculture (Amsterdam, Netherlands)

 
Description Although the project is still officially finished we are still analysing results from samples that arrived late into the laboratory as a result of Covid. Work from the project is still being written up for publication.

Through a Scottish case study on anaemia in salmon aquaculture information gathered from questionnaires has helped to identify the type of anaemia experienced in most cases by Scottish aquaculture is regenerative, resulting from loss of red blood cells (RBC) (haemorrhage) or destruction of RBC (haemolysis) and that it is most likely linked to blood loss via the fish gills during periods of gill health challenge. This study is currently under review in the journal Aquaculture (Anaemia in salmon aquaculture: Scotland
as a case study).

Several attempts were made to repurpose mammalian automated haematology analysers for use on fish blood. Two instruments from different manufacturers were tested with salmon blood and the results compared against manual analysis. Unfortunately, these instruments was unable to be manually gated to fish specific ranges and as such, the output data tended to be over- or under-estimate in certain blood parameters most likely due to the nucleated red blood cells. Further limitations with the instrument may exist with determination in cell size. In conclusion, at this stage, the reliability of automated haematological analysis of fish blood is not possible and thus, to produce reliable diagnostic results we found that manual methods are necessary.

Fish whole blood preservation was investigated as haematology analysis needs to be undertaken on fresh whole blood, but often the laboratory is a considerable distance from the point of sampling, resulting in sample degradation. The aim of this preliminary work was to test if various concentrations of neutral buffered formalin (NBF) could be used to fix whole blood and still maintain the structure and integrity of red blood cells (RBCs) and white blood cells (WBCs) to halt the degradation of whole blood for analysis. The most significant lysis of RBCs was present in 10% neutral buffered formalin (NBF) with the least identified in 1% NBF. In contrast to our results, Arnold et al found that preserving fresh WB in 10% NBF is a reliable method to maintain cell morphology for manual cell counts for up to 1 month. Our results from microscopy showed that there was a significant reduction in the number of RBCs compared to the whole blood smear, cellular integrity is compromised which can be identified by the lysis of RBCs, cracking (may indicate problems with proteins), free nuclei and shrinking of RBCs and WBCs.

The Nova Biomedical Statstrip diagnostics point of care device is suitable for rapid, on-site assessment of anaemia of Atlantic salmon through the measurement of haemoglobin and haematocrit. Validation is complete and is currently being written up for publication.

Our initial investigations into the development of automated haematology image analysis on Atlantic salmon blood smears in collaboration with Olympus using the Scan R software are showing promising results. It is intended that this method will develop into a fully automated system allowing the rapid analysis of large numbers of smears replacing the need for time consuming manual analysis. This approach formed the basis for a BBSRC Follow on Funding application in partnership with Olympus, Fortress Diagnostics and Nova biomedical. However, this application was not successful.
Exploitation Route It is intended that the datasets and techniques developed in this project shall be developed further and offered as a commercial service to the Scottish aquaculture industry through the company (WellFish Diagnostics) currently being developed under the Scottish Enterprise High Growth Spinout Programme grant awarded to Professor Quinn and housed in the UWS Aquaculture Health Laboratory. The results generated shall also be published in international peer reviewed journals, therefore accessible to the research community.
Sectors Agriculture, Food and Drink

 
Description The Nova medical Statstrip point of care device is currently being used by both of our aquaculture industry partners to measure haemoglobin and haematocrit, replacing the centrifuge based pack cell volumen method for measuring haematocrit. This is a faster, more efficient method, but is still undergoing validation. Due to the reliance on labour intensive, slow manual techniques, haematology has had limited use to assess fish health in the salmon aquaculture industry. Although still in the development phase, through our collaboration with Olympus Life Sciences Research we are currently adapting their Scan R imaging system for rapid cell differentiation from salmon blood smears. This approach will facilitate the development of haematology as a practical tool for the Scottish and international salmon aquaculture industry to assess fish health.
First Year Of Impact 2019
Sector Agriculture, Food and Drink
Impact Types Economic

 
Description Developing techniques to study Neoparamoeba species isolated from sea urchins (Ref SERS1-17)
Amount £5,300 (GBP)
Organisation Marine Alliance for Science and Technology for Scotland 
Sector Academic/University
Country United Kingdom
Start 06/2022 
End 12/2022
 
Description Evaluation and optimisation of thermal delicing in Scottish salmonid aquaculture
Amount £150,000 (GBP)
Organisation Scottish Aquaculture Innovation Centre 
Sector Multiple
Country United Kingdom
Start 04/2021 
End 03/2022
 
Description High Growth Spinout Programme (HGSP)
Amount £191,000 (GBP)
Funding ID PS730573C 
Organisation Scottish Enterprise 
Sector Public
Country United Kingdom
Start 09/2019 
End 10/2021
 
Description High Growth Spinout Programme Phase 2
Amount £123,000 (GBP)
Organisation Scottish Enterprise 
Sector Public
Country United Kingdom
Start 02/2021 
End 08/2021
 
Description The clinical significance of blood biochemical parameters as a rapid diagnostic indicator of health status in salmonid aquaculture.
Amount £200,775 (GBP)
Funding ID RD040 
Organisation Centre For Environment, Fisheries And Aquaculture Science 
Sector Public
Country United Kingdom
Start 04/2020 
End 09/2021
 
Title Adaption of Olympus Scan R software for haematological assessment of salmon blood. 
Description We are collaborating with Olympus Life Sciences Research for the adaptation and validation of their Scan R AI Software for the identification and differentiation of differnet haematological cell types in salmon blood smears. Differentation of cell types in fish blood is notoriously difficult and we are currently working with Olympus to teach the software how to differentiate between the different cell types. Once a significant backgrond level for each cell type has been established the software shall automatically be able to scan the smears, replacing the need for time consuming manual analysis. 
Type Of Material Physiological assessment or outcome measure 
Year Produced 2020 
Provided To Others? No  
Impact Haematology is rarely used in fish health assessment owing to the reliance on slow, time consuming manual techniques that are often relatively subjective. The development of an automated method to read blood smears enabling cell differentiation shall facilitate the use of haematological analysis in fish health assessment for the Scottish and international aquaculture sector. Through the Scottish Enterprise HGSP supported spinout company, we shall offer this service on a commercial basis to the Scottish aquaculture sector, providing consistent, objective results with rapid (48h) analysis. Development of this tool shall greatly enhance animal welfare allowing the early identification of anaemia and other blood based health challenges. 
 
Title High throughput clinical chemistry to assess anaemia. 
Description Blood serum from anaemic fish was tested for numerous clinical chemistry endpoints to identify the potential cause/type of anaemia observed. These endpoints cannot be listed (for IP purposes) but include endpoints to measure the impact on gill, kidney, liver, heart, muscle and general homeostasis. This work is currently being written up for publication under the working title: 'A novel approach to identify anaemia in Atlantic salmon using blood biochemistry'. 
Type Of Material Technology assay or reagent 
Year Produced 2020 
Provided To Others? No  
Impact Repurpose of high throughput, automated clinical chemistry instrumentation (Monarch 400) for use on fish blood. Where necessary the instrument settings have been altered to accommodate the endpoint range for fish. In this project these endpoints have been used to investigate the impact of anaemia on fish helping to identify the type of anaemia and potentially its source. This approach has been commercialised through the Scottish Enterprise High Growth Spinout Programme and is currently being offered commercially to the Scottish aquaculture sector through the spinout company WellFish Diagnostics Ltd. 
URL https://www.wellfishdiagnostics.com/
 
Title Repurpose of automated mammalian haematology analysers for fish blood 
Description The scil Vet abc Plus™ was assessed to identify the validity of haematology results using farmed Atlantic salmon (Salmo salar) blood. The Scil Vet abc Plus produces a complete four-part differential blood count using 10 µl of anticoagulated whole blood. The instrument uses impedance technology which measures changes in electrical resistance produced by a particle therefore it can count cells and measure the size of WBCs, RBCs and platelets in animals. The software was pre-installed with 9 mammalian species (dog, cat, horse, cattle, rabbit, rat, mouse, sheep and pig). Unfortunately, the instrument was unable to be manually gated to fish specific ranges and as such, the output data tended to be over- or under-estimate in certain blood parameters most likely due to the nucleated red blood cells. Further limitations with the instrument may exist with determination in cell size. 
Type Of Material Technology assay or reagent 
Year Produced 2020 
Provided To Others? No  
Impact In conclusion, at this stage, the reliability of automated haematological analysis of fish blood is not possible and thus, to produce reliable diagnostic results we found that manual methods are necessary. 
 
Title Validation of Point of Care medical tools for use in salmon aquaculture 
Description Working with Nova Biomedical for the validation of the StatStrip Hb/HCT hand held point of care analyser to assess anaemia in aquaculture reared Atlantic salmon. Haemaglobin and haematocrit measurements have been compared against the standard lab based Drabkin's and centrifuge based packed cell volume methods respectively. Both of these endpoints are central for the identification of anaemia and more consistant, rapid methods are needed to undertake the large scale sampling needed by the industry to investigate anaemia in salmon aquaculture. This work is currently being written up for publication under the working title: 'Validation of point of care devices for use in salmonid aquaculture'. 
Type Of Material Physiological assessment or outcome measure 
Year Produced 2020 
Provided To Others? No  
Impact The adaptation of these medical diagnostic point of care analysers used by fish health managers for on-site anaemia assessment in fish shall increase fish welfare and health status by allowing the rapid diagnosis of anaemia. The integrated of this data with serum clinical chemistry analysis they shall not only provide information on the level of anaemia present in the fish, but what tissues it is impacting, which will help to identify the type of anaemia, providing information on its potential source. 
 
Title Atlantic salmon haematology database 
Description Although there is published work on the different cell types in Atlantic salmon haematology, there is currently no database on cell differentiation from aquaculture reared Atlantic salmon available for clinical interpretation. The development of automated methods for blood smear assessment is allowing the UWS Aquaculture Health Laboratory to develop a large scale haematology database over a growing cycle to be used as a reference library to enable clinical interpretation. Although this work is underway, the database shall continue to develop over the coming years, as our knowledge of salmon haematology grows. 
Type Of Material Database/Collection of data 
Year Produced 2020 
Provided To Others? No  
Impact This dynamic haematology database shall enable the widespread use of haematology as a tool for the health and welfare assessment of aquaculture reared Atlantic salmon. The database shall be available to the spinout company established under the Scottish Enterprise High Growth Spinout Programme to offer haematology analysis commercially to the Scottish and international salmon aquaculture industry. 
 
Description Fortress Diagnostics 
Organisation Fortress Diagnostics
Country United Kingdom 
Sector Private 
PI Contribution To investigate the impact of anaemia on fish we are undertaking both haematology and clinical chemistry analysis. The clinical chemistry endpoints help us to not only see the impact, but identify the type of anaemia, potentially indicating its source. To this end we are measuring the various biomarkers outlined in the project proposal (ALT, ALP, Total Bilirubin, Albumin, Creatinine, LDH, Chloride, Sodium, Potassium, Iron, Copper, Mg, Zc and total protein) and have also included Aldolase, Creatine Kinase and Ferritin. Fortress Diagnostics also supply Haematology analysers and we are currently investigating the use of the GLU-100Celldiff-3 instrument to undertake 3 part WBC differentials on fish blood. We have previously tried to use automated haematology analysers from different suppliers (Horiba ABC+ and Siemens Advia) with no success due to the fundamental differences between fish and mammalian blood. However working with Fortress and the manufacturer of the GLU-100Celldiff-3 instrument we are adapting both the software and hardware to be specific to fish blood.
Collaborator Contribution The Aquaculture Health Laboratory in UWS has entered into a formal agreement with Fortress Diagnostics, who have provided us with a Monarch 240 clinical chemistry instrument at cost price, providing a saving of ~£10,000. They are also providing the clinical chemistry kits mentioned above at cost price, providing a further saving of ~£5,000. We have been sending fish serum and whole blood to their laboratories in Northern Ireland to test the cross reactivity of the various clinical chemistry endpoints and to investigate how to amend the haematology GLU-100Celldiff-3 instrument. This work is ongoing.
Impact We have had cross reactivity with all of the clinical chemistry endpoints investigated, with the exception of Ferritin. Clinical chemistry data has now been generated on the anaemia infected fish blood serum samples provided by our aquaculture industry partners. This shall be interpreted with manual classical haematology already undertaken on the samples and the haemoglobin and haematocrit results to provide a full picture of anaemia in these fish. This shall be written up as a publication once full data interpretation has been undertaken.
Start Year 2020
 
Description Nova Biomedical point of care haematology instrument validation for use on salmon blood 
Organisation Nova Biomedical
Country United Kingdom 
Sector Private 
PI Contribution In collaboration with our aquaculture industry partners we are validating the use of the 'StatStrip' human medical point of care devices for measurement of haemaglobin, haptoglobin, lactate, glucose and creatinine for use on fish farms to assess fish health. This is particularly relevant for haematocrit and haemaglobin measurement where we aim to use the StatStrip divice to replace the need for the time consuming centrifugation and lab based Drabkins methods respectively.
Collaborator Contribution Nova Biomedical have provided us with several StratStrip medical point of care devices for validation on fish blood. These include 3 haemaglobin/heamatocrit units (one for UWS and one each of our salmon industry partners Mowi and Scottish Salmon Company), 1 Glucose, 1 Lactate and 1 creatinine unit. Substantial numbers of consumables to enable testing of the high sample numbers (~1000) needed for method validation, have also been provided. Technical support has also been provided, particulalry in relation to data interpretation.
Impact We are still generating the large amount of data needed to validate this medical device for use on fish blood and intend to publish our findings in a relevant scientific journal (e.g. journal of fish diseases) when complete. We are also building up the valuable database needed for the clinical interpretation of the results generated. Access to samples on a working fish farm is always a challenge, so we have provided both aquaculture industry partners (Mowi and Scottish Salmon Company) with their own instruments for use by their fish health managers go help generate the substantial dataset needed for validation. The results from this work are currently being written up as a publication.
Start Year 2019
 
Description Olympus fish haematology image analysis. 
Organisation Olympus
Country Global 
Sector Private 
PI Contribution With the aim of adapting the Scan R automated software to identify and differentiate the different cell types in salmon blood smears we have provided Olympus Life Sciences Research with numerous (>150) scanned images of blood smears from healthy salmon to enable the software to differentiate between the different cell types. We have also identified for them the different cell types and stages of cell development.
Collaborator Contribution Scanned images of blood smears were send to Dr Manoel Veiga, an application specialist in Olympus Soft Imaging Solutions, Germany. We have had meetings with both Dr Veiga and Dr Daniel Hansen (Life Science Imaging Specialist in Olympus Scientific Solutions Division, UK) regarding the issues involved in the differentiation of fish cells as opposed to mammalian cells and Dr Veiga has been uploading the different cell types into the image analysis software to enable it to scan the blood smear images and properly identify the different cell types.
Impact This work only started in Jan 2020 so no outcomes have been developed yet. However, it is envisaged that in collaboration with Olympus we shall develop the background database library needed to enable the AI programme in the Scan R software to automatically detect the different cells and cell parameters to allow rapid haematology analysis and the efficient identification of anaemia in farmed salmon. This relationship was the basis of a BBSRC Follow on Funding application in 2020. However, this application was unsuccessful and we did not have the required funds to further develop this research.
Start Year 2020
 
Company Name WELLFISH DIAGNOSTICS LTD 
Description WellFish Diagnostics is a company that has spun out from UWS on the 1st September, 2021 as part of the Scottish Enterprise High Growth Spinout Programme. This company offers fish specific clinical chemistry analysis to the Scottish and international salmonid aquaculture industry and is developing novel blood tests for fish. The clinical chemistry methods used to investigate anaemia in this project shall be included in the company services. We have offered haematology analysis for our future clients, but as anaemia is currently no longer a major issue for the industry, they are not currently looking for this service. 
Year Established 2021 
Impact Although only 6 months old, we have signed supply agreements with 4 of the major salmon/trout producers in Scotland. We are regularly analysing blood serum samples sent to us from our customers and providing them with interpreted clinical chemistry data indicating the health status of their fish. This data is being used to inform husbandry decisions including feeding and treatment regimes. Our aim is to replace the reliance on lethal histopathology based methods by using non-lethal, blood based clinical chemistry analysis. In the short time this service has been available we have far exceeded the estimated demand and are beginning to make a significant contribution to maintaining the high standards of fish health and welfare required by the aquaculture sector.
Website http://www.wellfishdiagnostics.com
 
Description Article in Fish Farming Expert (aquaculture trade magazine), 'A pro-active model to assess fish health in aquaculture'. 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Industry/Business
Results and Impact Article was titled 'A pro-active model to assess fish health in aquaculture' and outlined the novel methods we are developing in the UWS Aquaculture Health Laboratory to assess fish health in aquaculture based on rapid, non-lethal automated clinical chemistry and haematology. Article written for a non-scientific, industry focused audience and was very well received.
Year(s) Of Engagement Activity 2019
 
Description Industry Partner Advisory Board 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Industry/Business
Results and Impact As part of my Scottish Enterprise High Growth Spinout Programme project I have an advisory board from the Scottish and International aquaculture industry. We met on the 28th Jan where my team and I presented our research, including the haematology techniques developed as part of this BBSRC grant. Our aim is to establish an commercial laboratory that will undertake fish health assessment for the aquaculture industry. This assessment is based on both clinical chemistry and haematology analysis. The advisory board provided us with the feedback needed to shape the company to meet the needs of the industry.
Year(s) Of Engagement Activity 2020